Arbutin vs Kojic Acid vs Ethyl Ascorbyl Ether: Which Should You Use?

By Liz Song, founder of ALTA MEET

If you’re sourcing a brightening serum or tone-correcting cream from a Korean ODM, you’ve probably seen these three names pop up on ingredient shortlists: alpha-arbutin, kojic acid dipalmitate, and ethyl ascorbyl ether. They’re the workhorses of Korean whitening formulation, and Korean chemists have been fine-tuning them for years.

Here’s the catch. In Korea, all three are recognized MFDS functional cosmetic ingredients for “whitening.” In the US, none of them gives you that claim. Understanding the science behind each one, plus the regulatory gap between Seoul and Washington, will save you from launching a product with claims that could get you flagged.

What Each Ingredient Actually Does

Alpha-Arbutin

Alpha-arbutin is a glycosylated hydroquinone, which sounds scarier than it is. Think of it as hydroquinone’s polite cousin: it binds to tyrosinase (the enzyme that kicks off melanin production) and slows things down without the cytotoxicity issues associated with hydroquinone itself. The binding is competitive and reversible, meaning it parks in tyrosinase’s active site and reduces its output without destroying melanocytes.

The European SCCS considers alpha-arbutin safe at up to 2% in face products and 0.5% in body products. Most Korean ODMs formulate at 1–2% in serums and creams. Beyond tyrosinase inhibition, alpha-arbutin also scavenges reactive oxygen species (ROS), giving it a mild antioxidant bonus that many formulators overlook.

Stability is a strong suit here. Alpha-arbutin holds up well across a wide pH range (roughly pH 3.5–6.5) and does not discolor formulas the way some brightening actives can. If your product sits in a clear bottle on a shelf for six months, alpha-arbutin will still look and perform the same.

Kojic Acid Dipalmitate

Standard kojic acid is a powerful tyrosinase inhibitor, but it has a reputation for being a formulation headache. It oxidizes easily, turns brown when exposed to light, and can irritate sensitive skin at higher concentrations. Kojic acid dipalmitate (KAD) solves most of these problems by esterifying the molecule with two palmitic acid chains.

The result is an oil-soluble ingredient that resists oxidation, heat, and light far better than its parent compound. Once KAD lands on the skin, esterases in the stratum corneum hydrolyze it back into kojic acid, delivering the active right where it’s needed. Because of its lipophilic nature, KAD has a higher affinity for the skin’s outer layers and may absorb more efficiently than water-soluble kojic acid.

Korean ODMs typically formulate KAD at 1–3% in emulsions and oil-based serums. The trade-off: KAD does not dissolve in water, so purely aqueous formulas are not a good fit. If your product concept is a lightweight water-gel, your chemist will probably steer you toward alpha-arbutin or ethyl ascorbyl ether instead.

Ethyl Ascorbyl Ether (3-O-Ethyl Ascorbic Acid)

Ethyl ascorbyl ether, also known as 3-O-ethyl ascorbic acid (EAA), is a vitamin C derivative that Korean ODMs love for its stability and multi-functional profile. Unlike pure L-ascorbic acid, which oxidizes rapidly and turns yellow in formulation, EAA resists degradation because the ethyl group at the 3-position shields the molecule.

EAA inhibits tyrosinase through a different pathway than arbutin or kojic acid. Research shows it works partly through Nrf2-mediated suppression of alpha-MSH signaling in keratinocytes, which reduces the “make more melanin” signal that UV-exposed skin cells send to melanocytes. Clinical studies have demonstrated visible brightening at concentrations as low as 2–3% within 28 days of twice-daily application.

The bonus: EAA retains many of the antioxidant and collagen-supportive properties of vitamin C. If you want a single active that handles brightening, photoprotection support, and anti-aging messaging, EAA is the multitasker of this group. It also plays well in both water and oil phases, giving your formulator more flexibility than KAD.

The MFDS vs FDA Regulatory Gap

This is where things get interesting for indie founders sourcing from Korea.

Korea’s MFDS maintains a specific “functional cosmetic” category for whitening. If your formula uses an approved whitening active at the designated concentration, the product can carry an official whitening claim in Korea without additional clinical data submission. Alpha-arbutin, kojic acid (and its esters), and ethyl ascorbyl ether all sit on that approved list.

The US has no equivalent system. Under the FDA framework (now reinforced by MoCRA), cosmetics cannot claim to change the structure or function of the body. “Whitening” implies a physiological change in melanin production, which pushes a product into drug territory. The FDA has not approved any of these three ingredients as OTC drug actives for skin lightening.

What does this mean in practice? Your Korean ODM might hand you a product brief that says “whitening serum.” You cannot put those words on a US label. For a deep dive into what you can and cannot say, check out our guide to labeling Korean skincare for the US market.

What You Can Actually Say on a US Label

The good news: you are not stuck with a blank label. The FDA draws the line at functional claims, not cosmetic benefit language. Here are some approaches that stay on the right side of the regulation:

Safe language: “Brightens the appearance of skin,” “helps reduce the look of dark spots,” “promotes a more even-looking complexion,” “visibly radiant skin.”

Risky language: “Whitens skin,” “inhibits melanin production,” “treats hyperpigmentation,” “lightens skin tone.”

The word “brightening” has become the industry standard because it describes appearance without implying a biological mechanism. Keep your copy focused on the look and feel of skin, not what’s happening at the cellular level, and you should be fine.

MoCRA also requires facility registration, product listing with the FDA, safety substantiation, and adverse event reporting. These obligations apply regardless of which active you choose. If you are still getting up to speed on MoCRA, our FDA import guide for Korean skincare covers the basics.

Side-by-Side Comparison

Here is how the three actives stack up across the factors that matter most for indie brand formulation:

Factor	Alpha-Arbutin	Kojic Acid Dipalmitate	Ethyl Ascorbyl Ether
Mechanism	Competitive tyrosinase inhibitor	Pro-drug; releases kojic acid on skin	Nrf2/α-MSH pathway + tyrosinase
Solubility	Water-soluble	Oil-soluble	Both water and oil phases
Typical Use Level	1–2%	1–3%	2–3%
Stability	Excellent across wide pH range	Excellent (far better than kojic acid)	Excellent (far better than L-ascorbic acid)
Best Format	Serums, essences, water gels	Emulsions, oil serums, creams	Serums, creams, essences
Bonus Benefits	Mild antioxidant, gentle on skin	Non-irritating, long shelf life	Antioxidant, collagen support, anti-aging
MFDS Whitening	Approved	Approved	Approved
US FDA Status	Cosmetic ingredient only	Cosmetic ingredient only	Cosmetic ingredient only

Which One Should You Choose?

The answer depends on your product format, your target consumer, and how many marketing angles you want from a single active.

Pick alpha-arbutin if you are formulating a lightweight, water-based serum or essence for sensitive skin. It is the gentlest of the three, the most studied, and the easiest to work with in aqueous systems. It is also the most consumer-recognized ingredient of the group, which helps with marketing.

Pick kojic acid dipalmitate if your product is an emulsion, cream, or oil-based formula. KAD’s oil solubility makes it a natural fit for richer textures, and its slow-release mechanism means less irritation risk. It is also a smart pick for products with long shelf-life requirements, since it resists discoloration far better than standard kojic acid.

Pick ethyl ascorbyl ether if you want a multifunctional active that brightens, fights free radicals, and supports collagen. EAA works in both water and oil phases, giving your chemist maximum flexibility. It also lets you tell a “vitamin C” story on the front of your packaging, which resonates strongly with US consumers who may not recognize arbutin or kojic acid by name.

Many Korean ODMs will also suggest combining two of these actives in a single formula for synergistic brightening. Alpha-arbutin plus ethyl ascorbyl ether is a popular pairing because they target different steps in the melanin pathway and both dissolve easily in water-based systems. If you are exploring other K-beauty actives for your line, our azelaic acid sourcing guide covers another ingredient worth considering alongside these three.

Frequently Asked Questions

Is alpha-arbutin the same as hydroquinone?

No. Alpha-arbutin is a glycoside of hydroquinone, meaning it has a sugar molecule attached that changes how it interacts with skin. Unlike hydroquinone, alpha-arbutin does not cause ochronosis or significant cytotoxicity at standard cosmetic concentrations (1–2%). It inhibits tyrosinase reversibly, while hydroquinone acts more aggressively.

Can I call my product a “whitening serum” in the US?

No. Under FDA rules, “whitening” implies a change in skin structure or function, which would classify your product as a drug. Use “brightening” or language that describes appearance (“helps reduce the look of dark spots”) instead.

Which active works fastest?

Ethyl ascorbyl ether has shown visible brightening results in clinical studies within 9–28 days at 2–3% concentration. Alpha-arbutin and kojic acid dipalmitate typically take 4–8 weeks to show noticeable results, depending on concentration and formulation.

Can I combine all three in one product?

Technically yes, and some Korean ODMs do offer formulas with two or three of these actives together. However, combining all three raises formulation complexity and cost. Most chemists recommend pairing two complementary actives rather than stacking all three.